ArticleBioMed research international2019

Tenascin-C Is Increased in Inflammatory Bowel Disease and Is Associated with response to Infliximab Therapy.

Longui Ning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.